# Terlivaz

NDC: 43825-200
Generic name: Terlipressin
Labeler / Manufacturer: Mallinckrodt Hospital Products Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220914

FDA application: NDA022231

## Active ingredients

- TERLIPRESSIN: .85 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43825-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43825-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354